143 related articles for article (PubMed ID: 27590008)
1. Lentiviral expression system for the purification of secreted proteins from human cell cultures.
Falkenhagen A; Asad S; Read SE; Joshi S
BMC Biotechnol; 2016 Sep; 16(1):66. PubMed ID: 27590008
[TBL] [Abstract][Full Text] [Related]
2. A novel gene therapy strategy using secreted multifunctional anti-HIV proteins to confer protection to gene-modified and unmodified target cells.
Falkenhagen A; Ameli M; Asad S; Read SE; Joshi S
Gene Ther; 2014 Feb; 21(2):175-87. PubMed ID: 24305417
[TBL] [Abstract][Full Text] [Related]
3. Large-scale immunoaffinity purification of recombinant soluble human antigen CD4 from Escherichia coli cells.
Wells PA; Beiderman B; Garlick RL; Lyle SB; Martin JP; Herberg JT; Meyer HF; Henderson SL; Eckenrode FM
Biotechnol Appl Biochem; 1993 Dec; 18(3):341-57. PubMed ID: 8297511
[TBL] [Abstract][Full Text] [Related]
4. Production of lentiviral vectors by large-scale transient transfection of suspension cultures and affinity chromatography purification.
Segura MM; Garnier A; Durocher Y; Coelho H; Kamen A
Biotechnol Bioeng; 2007 Nov; 98(4):789-99. PubMed ID: 17461423
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral Vectors Mediate Long-Term and High Efficiency Transgene Expression in HEK 293T cells.
Mao Y; Yan R; Li A; Zhang Y; Li J; Du H; Chen B; Wei W; Zhang Y; Sumners C; Zheng H; Li H
Int J Med Sci; 2015; 12(5):407-15. PubMed ID: 26005375
[TBL] [Abstract][Full Text] [Related]
6. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
7. Suppression of HIV-1 infection in primary CD4 T cells transduced with a self-inactivating lentiviral vector encoding a membrane expressed gp41-derived fusion inhibitor.
Perez EE; Riley JL; Carroll RG; von Laer D; June CH
Clin Immunol; 2005 Apr; 115(1):26-32. PubMed ID: 15870017
[TBL] [Abstract][Full Text] [Related]
8. A convenient and general expression platform for the production of secreted proteins from human cells.
Aydin H; Azimi FC; Cook JD; Lee JE
J Vis Exp; 2012 Jul; (65):. PubMed ID: 22872008
[TBL] [Abstract][Full Text] [Related]
9. [Construction of a recombinant lentiviral vector of p38 MAPK and establishment of a human prostatic carcinoma cell line stably expressing p38 MAPK].
Jing YM; Luo J; Zhang YL; Chen SS; Wan P; Yan RH; Wang HC; Chen BH; Tan WL; Li HW
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):317-21. PubMed ID: 22445974
[TBL] [Abstract][Full Text] [Related]
10. Detailed design and comparative analysis of protocols for optimized production of high-performance HIV-1-derived lentiviral particles.
Mitta B; Rimann M; Fussenegger M
Metab Eng; 2005; 7(5-6):426-36. PubMed ID: 16102993
[TBL] [Abstract][Full Text] [Related]
11. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS.
Morgan RA; Looney DJ; Muenchau DD; Wong-Staal F; Gallo RC; Anderson WF
AIDS Res Hum Retroviruses; 1990 Feb; 6(2):183-91. PubMed ID: 2328156
[TBL] [Abstract][Full Text] [Related]
12. Functional Mimetics of the HIV-1 CCR5 Co-Receptor Displayed on the Surface of Magnetic Liposomes.
Kuzmina A; Vaknin K; Gdalevsky G; Vyazmensky M; Marks RS; Taube R; Engel S
PLoS One; 2015; 10(12):e0144043. PubMed ID: 26629902
[TBL] [Abstract][Full Text] [Related]
13. Generation of a packaging cell line for prolonged large-scale production of high-titer HIV-1-based lentiviral vector.
Ni Y; Sun S; Oparaocha I; Humeau L; Davis B; Cohen R; Binder G; Chang YN; Slepushkin V; Dropulic B
J Gene Med; 2005 Jun; 7(6):818-34. PubMed ID: 15693055
[TBL] [Abstract][Full Text] [Related]
14. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors.
Kafri T; Blömer U; Peterson DA; Gage FH; Verma IM
Nat Genet; 1997 Nov; 17(3):314-7. PubMed ID: 9354796
[TBL] [Abstract][Full Text] [Related]
15. Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells.
Gomatos PJ; Stamatos NM; Gendelman HE; Fowler A; Hoover DL; Kalter DC; Burke DS; Tramont EC; Meltzer MS
J Immunol; 1990 Jun; 144(11):4183-8. PubMed ID: 2341717
[TBL] [Abstract][Full Text] [Related]
16. HIV-1-based defective lentiviral vectors efficiently transduce human monocytes-derived macrophages and suppress replication of wild-type HIV-1.
Zeng L; Planelles V; Sui Z; Gartner S; Maggirwar SB; Dewhurst S; Ye L; Nerurkar VR; Yanagihara R; Lu Y
J Gene Med; 2006 Jan; 8(1):18-28. PubMed ID: 16142830
[TBL] [Abstract][Full Text] [Related]
17. High-level expression and purification of untagged and histidine-tagged HIV-1 reverse transcriptase.
Hou EW; Prasad R; Beard WA; Wilson SH
Protein Expr Purif; 2004 Mar; 34(1):75-86. PubMed ID: 14766302
[TBL] [Abstract][Full Text] [Related]
18. Targeting both viral and host determinants of human immunodeficiency virus entry, using a new lentiviral vector coexpressing the T20 fusion inhibitor and a selective CCL5 intrakine.
Petit N; Dorgham K; Levacher B; Burlion A; Gorochov G; Marodon G
Hum Gene Ther Methods; 2014 Aug; 25(4):232-40. PubMed ID: 25045917
[TBL] [Abstract][Full Text] [Related]
19. Influence of short-term adenoviral vector and prolonged lentiviral vector mediated bone morphogenetic protein-2 expression on the quality of bone repair in a rat femoral defect model.
Virk MS; Conduah A; Park SH; Liu N; Sugiyama O; Cuomo A; Kang C; Lieberman JR
Bone; 2008 May; 42(5):921-31. PubMed ID: 18295562
[TBL] [Abstract][Full Text] [Related]
20. New protocol for lentiviral vector mass production.
Segura MM; Garnier A; Durocher Y; Ansorge S; Kamen A
Methods Mol Biol; 2010; 614():39-52. PubMed ID: 20225034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
